Cornerstone Advisors (Washington)’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$399K Sell
2,326
-45
-2% -$8.31K 0.04% 56
2020
Q2
$455K Buy
2,371
+70
+3% +$11.5K 0.05% 46
2020
Q1
$339K Buy
2,301
+211
+10% +$33.6K 0.05% 46
2019
Q4
$324K Buy
2,090
+39
+2% +$5.62K 0.04% 63
2019
Q3
$277K Buy
2,051
+34
+2% +$4.46K 0.04% 63
2019
Q2
$246K Buy
2,017
+61
+3% +$6.76K 0.02% 121
2019
Q1
$203K Buy
1,956
+1,751
+854% +$181K 0.02% 133
2018
Q4
$23K Buy
205
+7
+4% +$750 ﹤0.01% 481
2018
Q3
$23K Hold
198
0.01% 504
2018
Q2
$21K Hold
198
0.01% 493
2018
Q1
$19K Sell
198
-115
-37% -$10.9K 0.01% 511
2017
Q4
$27K Hold
313
0.02% 423
2017
Q3
$24K Hold
313
0.02% 445
2017
Q2
$24K Hold
313
0.01% 455
2017
Q1
$23K Hold
313
0.01% 463
2016
Q4
$19K Sell
313
-34
-10% -$2.08K 0.02% 505
2016
Q3
$22K Buy
347
+308
+790% +$20.5K 0.02% 471
2016
Q2
$2K Hold
39
﹤0.01% 749
2016
Q1
$2K Buy
39
+8
+26% +$453 ﹤0.01% 753
2015
Q4
$2K Hold
31
﹤0.01% 747
2015
Q3
$2K Hold
31
﹤0.01% 744
2015
Q2
$2K Hold
31
﹤0.01% 616
2015
Q1
$2K Hold
31
﹤0.01% 644
2014
Q4
$2K Buy
+31
New +$1.62K ﹤0.01% 614

Other funds holding RMD

Cornerstone Advisors (Washington)'s RMD Position: Q3 2020 in Review

Cornerstone Advisors (Washington) reduced its ResMed (RMD) stake by 1.9% in Q3 2020, selling an estimated $8.31K and leaving 2,326 shares worth $399K. The position accounts for 0.04% of the portfolio, ranked #56.

Cornerstone Advisors (Washington) first reported a position in RMD in Q4 2014 and has held it in 24 quarters since. The position peaked at $455K in Q2 2020. 627 funds tracked by Wall St. Rank hold RMD as of Q3 2020.

  • Cornerstone Advisors (Washington) held 2,326 shares of ResMed worth $399K as of Q3 2020.
  • Cornerstone Advisors (Washington) sold 45 ResMed shares in Q3 2020, an estimated $8.31K.
  • ResMed made up 0.04% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #56 holding.
  • Cornerstone Advisors (Washington) first reported a position in ResMed in Q4 2014 and has held it in 24 quarters since.
  • Cornerstone Advisors (Washington)'s ResMed position peaked at $455K in Q2 2020.
  • 627 funds tracked by Wall St. Rank held ResMed as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.